Outcome of patients with sarcoidosis refractory to TNF antagonists: a case series

Background: Tumor necrosis factor (TNF) antagonists have been reported as an efficient third-line therapy for sarcoidosis but there is no data regarding patients who do not respond to this treatment. Objective: To report the characteristics, the outcome and the response to therapy of patients with s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sarcoidosis Vasc Diffuse Lung Dis
Autors principals: Thery-Casari, Clémence, Jamilloux, Yvan, Bouvry, Diane, Chapelon-Abric, Catherine, Marquet, Alicia, Bielefeld, Philip, Schleinitz, Nicolas, Vukusic, Sandra, Girszyn, Nicolas, Fain, Olivier, Bonnet, Fabrice, Valeyre, Dominique, Seve, Pascal
Format: Artigo
Idioma:Inglês
Publicat: Mattioli 1885 2018
Matèries:
Case Series
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7170127/
https://ncbi.nlm.nih.gov/pubmed/32476925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.36141/svdld.v35i4.6999
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars